Results 161 to 170 of about 66,586 (258)

Associations Between Body Composition and Metabolic Health in Children With Obesity

Maternal &Child Nutrition, EarlyView.
ABSTRACT Childhood obesity is an increasing public health problem with heterogeneous metabolic health outcomes. In children, distinguishing differences in body composition between individuals with metabolically healthy obesity (MHO) and those with metabolic syndrome (MS) may be useful for understanding the impact of body composition on metabolic health.
Desiree Lopez‐Gonzalez, Patricia Clark, Nayely Garibay‐Nieto, Pamela Reyes‐Delpech, Rodolfo Pérez, America Miranda‐Lora   +5 more
wiley   +1 more source

Brown adipose tissue

, 2015
Anna Maffione, Arlene Campos, Mostafa Elfeky   +2 more
openaire   +2 more sources

Alterations of Growth Performance, Blood Parameters, and Antioxidant Function of Brown Adipose Tissue in Mice Exposed to Cold. [PDF]

Antioxidants (Basel)
Zhang X, Jin X, Han Z, Jiang M, Shi B.
europepmc   +1 more source

Beyond Deterministic Fetal Programming: Intrauterine Exposures and the Multifactorial Origins of Adiposity

Obesity Reviews, EarlyView.
ABSTRACT Excess adiposity is not a recently developed problem but has existed since at least the upper Paleolithic, allowing evolutionary selection pressures to adapt the physiology of the pregnant woman and the feto‐placental unit for maternal and fetal protection.
Gernot Desoye, Ursula Hiden, Evelyn Jantscher‐Krenn, Herbert Fluhr, Jonathan C. Wells, Sonja Entringer, Mireille N. M. van Poppel   +6 more
wiley   +1 more source

Increased 99m Tc-MAA Uptake in Supraclavicular Brown Adipose Tissue in a Pediatric Patient With Hereditary Hemorrhagic Telangiectasia. [PDF]

Clin Nucl Med
Lu X, Zhang B, Lv C, Wang W, Yang J.
europepmc   +1 more source

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

Obesity Reviews, EarlyView.
ABSTRACT GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better ...
Giorgia Rutigliani, Tzu‐Wen L. Cross, Erica de Jong, Emily S. Glover, Ivan D. Mendoza, Mojisola Adisa, Keigo Tomoo, Xinyi Zhou, Richard D. Mattes   +8 more
wiley   +1 more source

Brown Adipose Tissue and Metabolic Markers Differ Between Greenlanders and Danes With Cold Activation.

J Clin Endocrinol Metab
Motzfeldt Jensen M, Almasi CE, Kjærgaard B, Rasmussen BS, Andersen MK, Schubert M, Hansen T, Ellervik C, Schéele C, Jørgensen ME, Andersen S.   +10 more
europepmc   +1 more source

ELOVL3 regulates phospholipid homeostasis and thermogenesis in brown adipose tissue. [PDF]

J Lipid Res
Qin Z, Wang P, Lu M, Tang Y, Ren Q, Chen FJ, Zhang WJ, Wei C.   +7 more
europepmc   +1 more source

Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction

Obesity Reviews, EarlyView.
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey, Irene Pomares‐Bri, Paula de Juan‐Maciá, Mariló Olivares‐Vicente, Enrique Barrajón‐Catalán, Vicente Micol, Enrique Roche, María Herranz‐López   +7 more
wiley   +1 more source

Palmitic acid induces UCP1-independent mitochondrial depolarization specifically in brown adipose tissue. [PDF]

J Biol Chem
Ishikawa Y, Shiiba I, Kozakura E, Yabu H, Hirose S, Oshio H, Yamada KI, Okamatsu-Ogura Y, Inatome R, Yanagi S.   +9 more
europepmc   +1 more source